Home » Newsletters » BioWorld Science

BioWorld Science

July 17, 2000

View Archived Issues

Activity of tucaresol determined in mouse models of visceral leishmaniasis

AIDS vaccine designed for Africa to begin phase I testing

HERS study shows increased venous thromboembolic risk with HRT

SkyePharma and Kirin Brewery enter drug delivery contract

Cafcit reduces apnea of prematurity

FDA advisory committee recommends against approval of OTC Mevacor

New formulations of RenaGel approved for use by FDA

LMWH such as enoxaparin claimed for use in motor neuron diseases

Company Profile: AGY Therapeutics

Profile of new melatonin agonist TAK-375 with natural-type effects on sleep

Microbially produced macrolide antifungal agent discovered in Spain

SNAP-7915: a promising new therapy for BPH designed by Synaptic and Merck team

Biopure reaches enrollment milestone in pivotal phase III trial of Hemopure

CETP inhibitor JTT-705 favorably affects lipid profiles, prevents progression of atherosclerosis

Pharmacopeia achieves milestone in Organon collaboration

Chiron and Aventis Pasteur team up to promote and market vaccines

Santarus initiates phase II trial of delayed-release azathioprine for treatment of Crohn's disease

Design, synthesis and biological profile of selective adenosine A2A agonist reported at Purines 2000

Abbott develops novel, orally active AK inhibitor with analgesic and antiinflammatory properties

New formulation of perospirone examined for efficacy and safety in schizophrenic patients

The former Warner-Lambert claims use of MEK kinase inhibitors for transplant rejection

Potassium channel modulators with antiischemic activity identified at BMS

Berlex presents newly synthesized series of anticoagulants

Novel DPP-IV inhibitors and their potential in NIDDM

Analgesic activity described for substituted cycloheptenes synthesized at Gruenenthal

Potent, broad-spectrum carbapenems in development at Sankyo

Takeda's new neuroprotectants useful for Alzheimer's disease and Parkinson's disease

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 4, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 4, 2025.
First phase of synthetic human genome project successfully completes
BioWorld
The first phase of the U.K. synthetic human genome project has successfully completed, realizing key steps in chromosome synthesis. The work has demonstrated a...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Laigo raises €11.5M seed money for targeted protein degradation
BioWorld Science
Laigo Bio BV has raised €11.5 million (US$13.7 million) in a seed round for the further development of a new approach to inducing targeted protein degradation by...